Jinyu Bio-Technology Co Stock

Jinyu Bio-Technology Co EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Jinyu Bio-Technology Co (600201.SS) as of Jul 26, 2026 is 180.42. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 59.11 — a change of 205.21% (higher).

EV/EBIT

180.42

YoY

205.21%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Jinyu Bio-Technology Co is 2026 180.42 . EV/EBIT (Enterprise Value to EBIT) of Jinyu Bio-Technology Co was 2025 59.11 . It decreases by 205.21% higher compared to the previous year.

The Jinyu Bio-Technology Co EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
74.56 base
Jan 1, 2020
54.31 base
Jan 1, 2021
44.61 base
Jan 1, 2022
35.20 base
Jan 1, 2023
40.43 base
Jan 1, 2024
78.77 base
Jan 1, 2025 (e)
70.02 base
Jan 1, 2026 (e)
40.53 base
YEARPRICE-TO-EBIT
2026 est 40.53
2025 est 70.02
2024 78.77
2023 40.43
2022 35.20
2021 44.61
2020 54.31
2019 74.56
2018 23.11
2017 28.77
2016 24.81
2015 36.60
2014 20.79
2013 30.66
2012 23.46
2011 17.87
2010 28.53
2009 26.43
2008 13.39
2007 32.31
2006 24.95
2005 11.54
Access this data via the Eulerpool API
Get Free API Key

Jinyu Bio-Technology Co Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Jinyu Bio-Technology Co's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Jinyu Bio-Technology Co's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Jinyu Bio-Technology Co's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Jinyu Bio-Technology Co grows earnings faster than its peers.

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

EV/EBIT (Enterprise Value to EBIT) of Jinyu Bio-Technology Co is 180.42 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Jinyu Bio-Technology Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Jinyu Bio-Technology Co